Bayer and Dewpoint Therapeutics $100M partnership in cardiovascular and gynaecological diseases gains significant media attention
The announcement of Dewpoint Therapeutics $100M partnership Bayer to research new treatments for cardiovascular and gynecological diseases has received significant […]